Nutraceuticals Market By Type (Prebiotics, Protein And Amino Acids, Omega-3 Fatty Acids, Minerals, Vitamins, Carotenoids, Fibers And Specialty Carbohydrates, Phytochemical And Plant), By Application (Functional Foods, Functional Beverages, Dietary Supplements, Animal Nutrition, Personal Care), By Health Benefits (Weight Management, Nutrition, Immunity, Bone Health, Heart Health, Gut), Industry Size, Growth, Share And Forecast To 2022
Key Findings
Nutraceuticals are ingredients of food and beverages having large number of health benefits such as providing nutrition, assisting in weight management, heart health, bone health etc. The global nutraceuticals is expected to grow at a CAGR of 7.7%. There is a continuous rise in the number of health conscious people around the world who are more inclined towards dietary supplements and nutritious products. Also the rising geriatric population around the globe is driving the demand of nutraceuticals. Due to these large number of industries are finding the application of nutraceuticals. Some of the challenges faced by the industry are higher cost involved in the R&D activities.
Market Segment Insight
The market is majorly segmented on the basis of type, application and health benefits. On the basis of types the market is segmented as prebiotics, protein and amino acids, omega-3 fatty acids, minerals, vitamins, carotenoids, fibers and specialty carbohydrates, phytochemical and plant extracts and other ingredients. On the basis of application themarket is segmented as functional foods, functional beverages, dietary supplements, animal nutrition, and personal care. On the basis of health benefits the market is segmented as weight management, nutrition, immunity, bone health, heart health, gut health.
Dietary supplements leads to largest revenue generation as compared to the other applications of nutraceuticals this is due to the rising awareness about the health benefits of the products and increasing number of health conscious people and over aged people requiring the supplements around the globe.
Regional Insight
Based on application the market is segmented into North America, Europe, APAC and ROW. APAC has the largest market share followed by North America Europe and ROW.APAC is expected to grow significantly due to increasing investment in healthcare industry and rising geriatric population.
Competitive Insights
The major key players who are contributing in the development of Nutraceuticals market are Ajinomoto Inc., BASF SE , FMC Corporation, Ingredion Incorporated etc. Key strategies adopted by companies areconsumer education, expansion, mergers and acquisition.
CHAP 1. METHODOLOGY & SCOPE 12
1.1. RESEARCH METHODOLOGY 12
1.2. RESEARCH SCOPE & ASSUMPTIONS 12
1.3. LIST OF DATA SOURCES 12
CHAP 2. EXECUTIVE SUMMARY 13
2.1. NUTRACEUTICALS MARKET SUMMARY & KEY BUYING CRITERIA 13
2.2. NUTRACEUTICALS MARKET OUTLOOK 13
2.3. MARKET SEGMENTATION ANALYSIS 13
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
2.5. NUTRACEUTICALS MARKET VALUE CHAIN ANALYSIS 13
2.6. VENDOR LANDSCAPE 13
CHAP 3. NUTRACEUTICALS MARKET 14
3.1. MARKET DRIVER ANALYSIS 14
3.1.1. RISING LIFE EXPECTANCY & RISE IN NUMBER OF HEALTH CONCIOUS PEOPLE 14
3.1.2. RISING DEMAND OF DIETARY SUPPLEMENTS 14
3.1.3. APPLICATION IN LARGE RANGE OF SEGMENTS 14
3.2. MARKET RESTRAINT ANALYSIS 14
3.2.1. HIGH COST OF R&D ACTIVITIES 14
3.3. KEY OPPORTUNITIES 14
3.3.1. RISING DEMAND IN EMERGING ECONOMIES 14
3.3.2. TECHNOLOGICAL ADVANCEMENTS 14
3.4. CHALLENGES 14
3.4.1. LACK OF AWARENESS 14
3.4.2. RISE OF MULTI PAGE LABELING 14
CHAP 4. INDUSTRY ANALYSIS 15
4.1. NUTRACEUTICALS MARKET– PORTER’S FIVE FORCE MODEL 15
4.2. NUTRACEUTICALS MARKET– PESTEL ANALYSIS 15
4.3. NUTRACEUTICALS MARKET– GAP ANALYSIS 15
CHAP 5. NUTRACEUTICALS MARKET BY TYPE 2012-2022 ($ BILLION) 16
5.1. GLOBAL NUTRACEUTICALS MARKET BY PREBIOTICS, 2012-2022 ($ BILLION) 16
5.2. GLOBAL NUTRACEUTICALS MARKET BY PROTEIN AND AMINO ACIDS, 2012-2022 ($ BILLION) 16
5.3. GLOBAL NUTRACEUTICALS MARKET BY OMEGA-3 FATTY ACIDS , 2012-2022 ($ BILLION) 16
5.4. GLOBAL NUTRACEUTICALS MARKET BY MINERALS, 2012-2022 ($ BILLION) 16
5.5. GLOBAL NUTRACEUTICALS MARKET BY VITAMINS, 2012-2022 ($ BILLION) 16
5.6. GLOBAL NUTRACEUTICALS MARKET BY CAROTENOIDS, 2012-2022 ($ BILLION) 16
5.7. GLOBAL NUTRACEUTICALS MARKET BY FIBERS AND SPECIALITY CARBOHYDRATES, 2012-2022 ($ BILLION) 16
5.8. GLOBAL NUTRACEUTICALS MARKET BY PHYTOCHEMICAL AND PLANT EXTRACTS, 2012-2022 ($ BILLION) 16
5.9. GLOBAL NUTRACEUTICALS MARKET BY OTHER INGREDIENTS, 2012-2022 ($ BILLION) 16
CHAP 6. NUTRACEUTICALS MARKET BY APPLICATION, 2012-2022 ($ BILLION) 17
6.1. GLOBAL NUTRACEUTICALS MARKET BY FUNCTIONAL FOODS, 2012-2022 ($ BILLION) 17
6.2. GLOBAL NUTRACEUTICALS MARKET BY FUNCTIONAL BEVERAGES, 2012-2022 ($ BILLION) 17
6.3. GLOBAL NUTRACEUTICALS MARKET BY DIETARY SUPPLEMENTS, 2012-2022 ($ BILLION) 17
6.4. GLOBAL NUTRACEUTICALS MARKET BY ANIMAL NUTRITION, 2012-2022 ($ BILLION) 17
6.5. GLOBAL NUTRACEUTICALS MARKET BY PERSONAL CARE, 2012-2022 ($ BILLION) 17
CHAP 7. NUTRACEUTICALS MARKET BY HEALTH BENEFITS 2012-2022($BILLION) 18
7.1. GLOBAL NUTRACEUTICALS MARKET BY WEIGHT MANAGEMENT, 2012-2022 ($ BILLION) 18
7.2. GLOBAL NUTRACEUTICALS MARKET BY NUTRITION, 2012-2022 ($ BILLION) 18
7.3. GLOBAL NUTRACEUTICALS MARKET BY IMMUNITY, 2012-2022 ($ BILLION) 18
7.4. GLOBAL NUTRACEUTICALS MARKET BY BONE HEALTH, 2012-2022 ($ BILLION) 18
7.5. GLOBAL NUTRACEUTICALS MARKET BY HEART HEALTH, 2012-2022 ($ BILLION) 18
7.6. GLOBAL NUTRACEUTICALS MARKET BY GUT, 2012-2022 ($ BILLION) 18
CHAP 8. NUTRACEUTICALS MARKET, REGIONAL OUTLOOK 2012-2022 ($ BILLION) 19
8.1. NUTRACEUTICALS MARKET BY REGION 2012-2022 ($ BILLION) 19
8.2. NORTH AMERICA 19
8.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 19
8.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.2.3.1. U.S. 19
8.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.2.3.2. CANADA 19
8.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.2.3.3. MEXICO 19
8.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.2.3.3.2. MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.3. EUROPE 20
8.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 20
8.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.3.3.1. GERMANY 20
8.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.3.3.2. UK 20
8.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.3.3.3. FRANCE 20
8.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.3.3.4. RUSSIA 20
8.3.3.4.1. RUSSIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.3.3.4.2. RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.3.3.5. REST OF EUROPE 20
8.3.3.5.1. OTHERS MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 21
8.3.3.5.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 21
8.4. ASIA PACIFIC 21
8.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
8.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 21
8.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
8.4.3.1. CHINA 21
8.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
8.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
8.4.3.2. INDIA 21
8.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
8.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
8.4.3.3. JAPAN 21
8.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
8.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 21
8.4.3.4. OTHERS 21
8.4.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 22
8.4.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 22
8.5. REST OF THE WORLD 22
8.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
8.5.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 22
8.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
8.5.3.1. LATIN AMERICA 22
8.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
8.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
8.5.3.2. MIDDLE EAST AND AFRICA 22
8.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
8.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
CHAP 9. COMPETITIVE LANDSCAPE 23
9.1. AJINOMOTO INC. 24
9.1.1. COMPANY OVERVIEW 24
9.1.2. SCOT ANALYSIS 24
9.1.3. PRODUCT BENCHMARKING 24
9.1.4. STRATEGIC INITIATIVES 24
9.2. ALAND (JIANGSU) NUTRACEUTICAL CO 24
9.2.1. COMPANY OVERVIEW 24
9.2.2. SCOT ANALYSIS 24
9.2.3. PRODUCT BENCHMARKING 24
9.2.4. STRATEGIC INITIATIVES 24
9.3. ARCHER DANIELS MIDLAND COMPANY 24
9.3.1. COMPANY OVERVIEW 24
9.3.2. SCOT ANALYSIS 24
9.3.3. PRODUCT BENCHMARKING 24
9.3.4. STRATEGIC INITIATIVES 24
9.4. ARLA FOODS 24
9.4.1. COMPANY OVERVIEW 24
9.4.2. SCOT ANALYSIS 24
9.4.3. PRODUCT BENCHMARKING 24
9.4.4. STRATEGIC INITIATIVES 24
9.5. ASSOCIATED BRITISH FOODS PLC 24
9.5.1. COMPANY OVERVIEW 24
9.5.2. SCOT ANALYSIS 24
9.5.3. PRODUCT BENCHMARKING 24
9.5.4. STRATEGIC INITIATIVES 24
9.6. BASF SE 24
9.6.1. COMPANY OVERVIEW 24
9.6.2. SCOT ANALYSIS 25
9.6.3. PRODUCT BENCHMARKING 25
9.6.4. STRATEGIC INITIATIVES 25
9.7. CARGILL, INCORPORATED 25
9.7.1. COMPANY OVERVIEW 25
9.7.2. SCOT ANALYSIS 25
9.7.3. PRODUCT BENCHMARKING 25
9.7.4. STRATEGIC INITIATIVES 25
9.8. E. I. DU PONT DE NEMOURS AND COMPANY 25
9.8.1. COMPANY OVERVIEW 25
9.8.2. SCOT ANALYSIS 25
9.8.3. PRODUCT BENCHMARKING 25
9.8.4. STRATEGIC INITIATIVES 25
9.9. FMC CORPORATION 25
9.9.1. COMPANY OVERVIEW 25
9.9.2. SCOT ANALYSIS 25
9.9.3. PRODUCT BENCHMARKING 25
9.9.4. STRATEGIC INITIATIVES 25
9.10. GROUPE DANONE S.A. 25
9.10.1. COMPANY OVERVIEW 25
9.10.2. SCOT ANALYSIS 25
9.10.3. PRODUCT BENCHMARKING 25
9.10.4. STRATEGIC INITIATIVES 25
9.11. INGREDION INCORPORATED 25
9.11.1. COMPANY OVERVIEW 25
9.11.2. SCOT ANALYSIS 25
9.11.3. PRODUCT BENCHMARKING 25
9.11.4. STRATEGIC INITIATIVES 25
9.12. KONINKLIJKE DSM N.V. 26
9.12.1. COMPANY OVERVIEW 26
9.12.2. SCOT ANALYSIS 26
9.12.3. PRODUCT BENCHMARKING 26
9.12.4. STRATEGIC INITIATIVES 26
9.13. TATE & LYLE PLC 26
9.13.1. COMPANY OVERVIEW 26
9.13.2. SCOT ANALYSIS 26
9.13.3. PRODUCT BENCHMARKING 26
9.13.4. STRATEGIC INITIATIVES 26
TABLE 1 GLOBAL NUTRACEUTICALS MARKET BY PREBIOTICS, 2012-2022 ($ BILLION) 27
TABLE 2 GLOBAL NUTRACEUTICALS MARKET BY PROTIEN AND AMINO ACIDS, 2012-2022 ($ BILLION) 27
TABLE 3 GLOBAL NUTRACEUTICALS MARKET BY OMEGA-3 FATTY ACIDS , 2012-2022 ($ BILLION) 27
TABLE 4 GLOBAL NUTRACEUTICALS MARKET BY MINERALS, 2012-2022 ($ BILLION) 27
TABLE 5 GLOBAL NUTRACEUTICALS MARKET BY VITAMINS, 2012-2022 ($ BILLION) 27
TABLE 6 GLOBAL NUTRACEUTICALS MARKET BY CAROTENOIDS, 2012-2022 ($ BILLION) 28
TABLE 7 GLOBAL NUTRACEUTICALS MARKET BY FIBERS AND SPECIALITY CARBOHYDRATES, 2012-2022 ($ BILLION) 28
TABLE 8 GLOBAL NUTRACEUTICALS MARKET BY PHYTOCHEMICAL AND PLANT EXTRACTS, 2012-2022 ($ BILLION) 28
TABLE 9 GLOBAL NUTRACEUTICALS MARKET BY OTHER INGREDIENTS, 2012-2022 ($ BILLION) 28
TABLE 10 28
TABLE 11 NUTRACEUTICALS MARKET BY APPLICATION, 2012-2022 ($ BILLION) 28
TABLE 12 GLOBAL NUTRACEUTICALS MARKET BY FUNCTIONAL FOODS, 2012-2022 ($ BILLION) 28
TABLE 13 GLOBAL NUTRACEUTICALS MARKET BY FUNCTIONAL BEVERAGES, 2012-2022 ($ BILLION) 28
TABLE 14 GLOBAL NUTRACEUTICALS MARKET BY DIETARY SUPPLEMENTS, 2012-2022 ($ BILLION) 28
TABLE 15 GLOBAL NUTRACEUTICALS MARKET BY ANIMAL NUTRITION, 2012-2022 ($ BILLION) 28
TABLE 16 GLOBAL NUTRACEUTICALS MARKET BY PERSONAL CARE, 2012-2022 ($ BILLION) 28
TABLE 17 NUTRACEUTICALS MARKET BY HEALTH BENEFITS 2012-2022($BILLION) 28
TABLE 18 GLOBAL NUTRACEUTICALS MARKET BY WEIGHT MANAGEMENT, 2012-2022 ($ BILLION) 28
TABLE 19 GLOBAL NUTRACEUTICALS MARKET BY NUTRITION, 2012-2022 ($ BILLION) 28
TABLE 20 GLOBAL NUTRACEUTICALS MARKET BY IMMUNITY, 2012-2022 ($ BILLION) 28
TABLE 21 GLOBAL NUTRACEUTICALS MARKET BY BONE HEALTH, 2012-2022 ($ BILLION) 28
TABLE 22 GLOBAL NUTRACEUTICALS MARKET BY HEART HEALTH, 2012-2022 ($ BILLION) 28
TABLE 23 GLOBAL NUTRACEUTICALS MARKET BY GUT, 2012-2022 ($ MILLION) 28
TABLE 24 NORTH AMERICA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 25 NORTH AMERICA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 29
TABLE 26 NORTH AMERICA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 27 U.S. NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 28 U.S. NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 29 CANADA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 30 CANADA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 –2022 ($ BILLION) 29
TABLE 31 CANADA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 32 MEXICO NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 33 EUROPE NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 34 EUROPE NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 29
TABLE 35 EUROPE NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 36 GERMANY NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 37 NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 38 UK NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 39 UK NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 40 ASIA PACIFIC NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 41 ASIA PACIFIC NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 30
TABLE 42 ASIA PACIFIC NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 43 CHINA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 44 CHINA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 45 INDIA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 46 INDIA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 47 JAPAN NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 48 JAPAN NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 49 MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 50 MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 51 LATIN AMERICA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 52 LATIN AMERICA NUTRACEUTICALS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
FIGURE 1 MARKET SHARE BY REGIONS 30
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 13 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)